Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental radioimmunotherapy.

D J Buchsbaum1

  • 1Division of Radiation Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Seminars in Radiation Oncology
|March 23, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus.

Cancer gene therapy·2014
Same author

Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling.

Oncogene·2013
Same author

Molecular targeted approaches for treatment of pancreatic cancer.

Current pharmaceutical design·2011
Same author

A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer.

Cancer chemotherapy and pharmacology·2010
Same author

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

Cancer gene therapy·2009
Same author

Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation.

Cancer gene therapy·2008
Same journal

Integrative Medicine for Breast Cancer Survivors.

Seminars in radiation oncology·2026
Same journal

Integrative Oncology Approaches for Gastrointestinal Symptoms and Risk Reduction in Patients With Digestive Tract Cancers.

Seminars in radiation oncology·2026
Same journal

Integrative Oncology and Radiation Therapy: An Essential Evolution.

Seminars in radiation oncology·2026
Same journal

Clinical Trials of Integrative Oncology Interventions for Radiation Therapy: Emerging Evidence and Opportunities.

Seminars in radiation oncology·2026
Same journal

Nonpharmacologic Approaches for Pain Management in Patients With Cancer Treated With Radiation Therapy.

Seminars in radiation oncology·2026
Same journal

Integrative Therapies for Radiation-Related Toxicities in Hematological Malignancies.

Seminars in radiation oncology·2026
See all related articles

Experimental radioimmunotherapy (RIT) research in animal models explores new targeting molecules and methods to improve cancer treatment efficacy. Further preclinical studies are vital for advancing clinical applications of radiolabeled antibodies and peptides.

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Immunotherapy

Background:

  • Experimental radioimmunotherapy (RIT) in animal models informs clinical RIT protocol design.
  • Direct translation of animal model results to clinical settings remains a challenge.

Purpose of the Study:

  • To review current experimental RIT research aimed at enhancing the therapeutic ratio.
  • To identify approaches likely to impact future clinical RIT study designs.

Main Methods:

  • Development of novel targeting molecules: engineered antibodies, fragments, fusion toxins, peptides.
  • Optimization of radiolabeling chemistry and radionuclide selection.
  • Exploration of administration routes, pretargeting strategies, and combination therapies.

Related Experiment Videos

Main Results:

  • Multiple strategies are being investigated to improve RIT efficacy, including molecular targeting, improved radiochemistry, and novel administration techniques.
  • Combination therapies, such as with external-beam radiation, chemotherapy, or gene therapy, show promise.

Conclusions:

  • Continued preclinical research with novel experimental approaches is essential for advancing cancer patient treatment using RIT.
  • Translating experimental RIT findings into effective clinical strategies requires further investigation in animal models.